January 14, 2016
Novartis Pharmaceuticals Corp. and Actavis LLC have agreed to settle claims that the generic drug maker's use of a drug ingredient infringed Novartis' patents, according to a court documents filed in New Jersey federal court on Thursday.
October 23, 2013
A New Jersey federal judge on Wednesday denied a bid by Apotex Inc. and other generic-drug makers to trim Novartis Pharmaceuticals Corp.'s suit against them, saying it was too early in the proceeding to determine whether their use of a drug ingredient infringed Novartis' patents.
May 01, 2013
Wockhardt USA LLC told a New Jersey federal judge Tuesday that three patent infringement suits launched by Novartis Pharmaceuticals Corp. seeking to block drugmakers from developing generic versions of its osteoporosis drug Reclast and oncology drug Zometa should be tried separately.